
J. Casimer Jacyna
Examiner (ID: 1992, Phone: (469)295-9095 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3754, 2403, 3751, 2899, 3105 |
| Total Applications | 3753 |
| Issued Applications | 2853 |
| Pending Applications | 166 |
| Abandoned Applications | 747 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18298010
[patent_doc_number] => 20230107696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/074168
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074168 | DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS | Dec 1, 2022 | Abandoned |
Array
(
[id] => 18484890
[patent_doc_number] => 20230212203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Antiviral Compounds
[patent_app_type] => utility
[patent_app_number] => 18/074219
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074219
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074219 | Antiviral Compounds | Dec 1, 2022 | Abandoned |
Array
(
[id] => 18878968
[patent_doc_number] => 20240002337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE
[patent_app_type] => utility
[patent_app_number] => 17/988753
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988753 | SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE | Nov 15, 2022 | Abandoned |
Array
(
[id] => 19845182
[patent_doc_number] => 20250090533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TAXANE
[patent_app_type] => utility
[patent_app_number] => 18/708487
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18708487
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/708487 | COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TAXANE | Nov 10, 2022 | Pending |
Array
(
[id] => 19998360
[patent_doc_number] => 20250136582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => SELECT KRAS G12C INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/708473
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18708473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/708473 | SELECT KRAS G12C INHIBITORS AND USES THEREOF | Nov 8, 2022 | Pending |
Array
(
[id] => 18391295
[patent_doc_number] => 20230159513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => PYRIDAZINONE COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/053318
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053318 | PYRIDAZINONE COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISEASES | Nov 6, 2022 | Issued |
Array
(
[id] => 18657582
[patent_doc_number] => 20230303489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/982187
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982187 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nov 6, 2022 | Pending |
Array
(
[id] => 19675894
[patent_doc_number] => 12187744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => IRAK4 degraders and synthesis thereof
[patent_app_type] => utility
[patent_app_number] => 18/050883
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24142
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050883 | IRAK4 degraders and synthesis thereof | Oct 27, 2022 | Issued |
Array
(
[id] => 18284739
[patent_doc_number] => 20230100211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
[patent_app_type] => utility
[patent_app_number] => 17/972008
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972008 | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) | Oct 23, 2022 | Pending |
Array
(
[id] => 18980137
[patent_doc_number] => 11905297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => OX2R compounds
[patent_app_type] => utility
[patent_app_number] => 17/971547
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 87
[patent_no_of_words] => 59919
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971547 | OX2R compounds | Oct 20, 2022 | Issued |
Array
(
[id] => 19060120
[patent_doc_number] => 11939328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Quinoline compounds as inhibitors of KRAS
[patent_app_type] => utility
[patent_app_number] => 18/046303
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77389
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046303 | Quinoline compounds as inhibitors of KRAS | Oct 12, 2022 | Issued |
Array
(
[id] => 18451408
[patent_doc_number] => 20230192686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/964423
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 710
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964423 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | Oct 11, 2022 | Pending |
Array
(
[id] => 18770807
[patent_doc_number] => 20230365605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/045647
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045647 | Bicyclic heteroaryl compounds and uses thereof | Oct 10, 2022 | Issued |
Array
(
[id] => 19717322
[patent_doc_number] => 12202845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Ras inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/938890
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 58635
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938890 | Ras inhibitors | Oct 6, 2022 | Issued |
Array
(
[id] => 18346253
[patent_doc_number] => 20230134363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ORGANIC COMPOUND AND SENSOR AND SENSOR EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/954986
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17954986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/954986 | Organic compound and sensor and sensor embedded display panel and electronic device | Sep 27, 2022 | Issued |
Array
(
[id] => 18405776
[patent_doc_number] => 20230167127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/934968
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 615
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934968 | COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION | Sep 22, 2022 | Pending |
Array
(
[id] => 19800440
[patent_doc_number] => 20250066365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => Ribonucleoside Analogues Against -Sars-Cov-2
[patent_app_type] => utility
[patent_app_number] => 18/694747
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694747 | Ribonucleoside Analogues Against -Sars-Cov-2 | Sep 22, 2022 | Pending |
Array
(
[id] => 18223981
[patent_doc_number] => 20230062975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HEPATITIS B CAPSID ASSEMBLY MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/947593
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947593 | HEPATITIS B CAPSID ASSEMBLY MODULATORS | Sep 18, 2022 | Abandoned |
Array
(
[id] => 18213745
[patent_doc_number] => 20230060011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/946587
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946587 | Antibacterial compounds | Sep 15, 2022 | Issued |
Array
(
[id] => 19226693
[patent_doc_number] => 12006326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Antiviral heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/894412
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50601
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894412 | Antiviral heterocyclic compounds | Aug 23, 2022 | Issued |